+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Glucose Monitoring (CGM) Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Countries, Company Analysis

  • PDF Icon

    Report

  • 300 Pages
  • September 2022
  • Region: Global
  • Renub Research
  • ID: 5654356

Global Continuous Glucose Monitoring Market reached US$ 5.78 Billion in 2021

According to the publisher, Continuous Glucose Monitoring Market is estimated to reach US$ 8.48 Billion by 2027. One of the most recent technical evolutions in diabetes management is continuous glucose monitoring (CGM). In brief, a CGM system is a form of glucose monitoring device that works by inserting a biosensor either transcutaneously or subcutaneously. Furthermore, the embedded sensor detects glucose levels in interstitial fluid or blood. It communicates the data to a receiver/monitor for display. Due to their numerous advantages over traditional glucose monitoring devices, these systems play an essential role in diabetes care. Unlike traditional glucose monitors, these devices allow for continuous glucose monitoring, which is critical for avoiding diabetic complications.

Global Continuous Glucose Monitoring Market Size Is Expanding with a CAGR Of 6.60% During 2021-2027

The spike in the geriatric population and the increasing prevalence of diabetes have been essential factors driving the CGM market's expansion over the years worldwide. Furthermore, as the number of diabetic cases rises, the market for continuous glucose monitoring systems is predicted to grow and expand, attracting and compelling many industry participants to develop innovative products or product line extensions. Moreover, substantial growth potential in undeveloped areas is expected to generate significant profit opportunities for manufacturers during the anticipated period. However, a lack of proper funding for devices is a substantial impediment to their widespread adoption.

COVID-19 Impact on Continuous Glucose Monitoring Industry

According to the World Health Organization (WHO), the number of people with type 2 diabetes has been rising in most nations, according to the World Health Organization (WHO). Furthermore, according to our findings, the COVID-19 epidemic has increased the necessity of evaluating the feasibility of continuous glucose monitoring (CGM) in hospitals to preserve personal protective equipment (PPE) and restrict exposure to health care workers. As a result, the Continuous Glucose Monitoring Market has grown even during the epidemic. Moreover, as per our analysis, Global Continuous Glucose Monitoring Market reached US$. 5.78 Billion in 2021.

Segment Analysis in Continuous Glucose Monitoring Market

The Global Continuous Glucose Monitoring Market is studied in the United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom, and Japan. Further, the market in detail is categorized based on Diabetes Population (Type 1 and Type 2, CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User, and CGM Reimbursement.

Competitive Landscape

The Continuous Glucose Monitoring (CGM) Market is highly competitive, with only a few companies competing. Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics are among the important players profiled in our analysis. These firms control a significant portion of the global market. In addition, they are continually entering new markets to develop new revenue streams and strengthen existing ones. These market actors' actions will create a competitive marketplace, forcing enterprises to experiment with the latest technology to maintain originality in their products. Companies are also working together to improve their technical knowledge and shorten the product development cycle.

The publisher's latest report “Continuous Glucose Monitoring (CGM) Market, Global Forecast, By Components (Glucose Sensor Market and CGM Transmitter Market), Countries (United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom and Japan), Country Insights (Diabetes Population (Type 1 and Type 2), CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User and CGM Reimbursement), Companies (Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics)” provides a detailed analysis of Continuous Glucose Monitoring (CGM) Industry.

By Components - the market has been studied based on 2 viewpoints

1. Glucose Sensor Market
2. CGM Transmitter Market

By Countries - the market has been studied for 11 countries

1. United States
2. Canada
3. Germany
4. Australia
5. France
6. Netherlands
7. Switzerland
8. Sweden
9. Israel
10. United Kingdom
11. Japan

The above-mentioned countries have been studied from 7 viewpoints

1. Diabetes Population
  • Type 1
  • Type 2
2. CGM Market
3. CGM Market by Components
4. Glucose Sensor Market
5. CGM Transmitter Market
6. CGM User
7. CGM Reimbursement

Company Insights

  • Overview
  • Recent Development
  • Revenue

Companies Covered

1. Abbott Laboratories
2. Roche
3. Tandem Diabetes Care
4. Dexcom Inc
5. Senseonics

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global CGM Market and User Analysis
5.1 Market
5.2 User
6. By Components - Continuous Glucose Monitoring Market
6.1 Glucose Sensor Market
6.2 CGM Transmitter Market
7. Global CGM Market and CGM User Share Analysis
7.1 CGM Market Share
7.1.1 Glucose Sensor Market Share
7.1.2 CGM Transmitter Market Share
7.2 CGM User Share
8. Global CGM (Continuous Glucose Monitoring) Reimbursement Model9. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)
10. United States
10.1 Diabetes Population
10.1.1 Type 1
10.1.2 Type 2
10.2 United States - CGM Market
10.2.1 United States - CGM Market by Components
10.2.1.1 Glucose Sensor Market
10.2.1.2 CGM Transmitter Market
10.3 United States - CGM User
10.4 CGM Reimbursement in United States
11. Canada
11.1 Diabetes Population
11.1.1 Type 1
11.1.2 Type 2
11.2 Canada - CGM Market
11.2.1 Canada - CGM Market by Components
11.2.1.1 Glucose Sensor Market
11.2.1.2 CGM Transmitter Market
11.3 Canada - CGM User
11.4 CGM Reimbursement in United States
12. Germany
12.1 Diabetes Population
12.1.1 Type 1
12.1.2 Type 2
12.2 Germany - CGM Market
12.2.1 Germany - CGM Market by Components
12.2.1.1 Glucose Sensor Market
12.2.1.2 CGM Transmitter Market
12.3 Germany - CGM User
12.4 CGM Reimbursement in United States
13. Australia
13.1 Diabetes Population
13.1.1 Type 1
13.1.2 Type 2
13.2 Australia - CGM Market
13.2.1 Australia - CGM Market by Components
13.2.1.1 Glucose Sensor Market
13.2.1.2 CGM Transmitter Market
13.3 Australia - CGM User
13.4 CGM Reimbursement in United States
14. France
14.1 Diabetes Population
14.1.1 Type 1
14.1.2 Type 2
14.2 France - CGM Market
14.2.1 France - CGM Market by Components
14.2.1.1 Glucose Sensor Market
14.2.1.2 CGM Transmitter Market
14.3 France - CGM User
14.4 CGM Reimbursement in United States
15. Netherlands
15.1 Diabetes Population
15.1.1 Type 1
15.1.2 Type 2
15.2 Netherlands - CGM Market
15.2.1 Netherlands - CGM Market by Components
15.2.1.1 Glucose Sensor Market
15.2.1.2 CGM Transmitter Market
15.3 Netherlands - CGM User
15.4 CGM Reimbursement in United States
16. Switzerland
16.1 Diabetes Population
16.1.1 Type 1
16.1.2 Type 2
16.2 Switzerland - CGM Market
16.2.1 Switzerland - CGM Market by Components
16.2.1.1 Glucose Sensor Market
16.2.1.2 CGM Transmitter Market
16.3 Switzerland - CGM User
16.4 CGM Reimbursement in United States
17. Sweden
17.1 Diabetes Population
17.1.1 Type 1
17.1.2 Type 2
17.2 Sweden - CGM Market
17.2.1 Sweden - CGM Market by Components
17.2.1.1 Glucose Sensor Market
17.2.1.2 CGM Transmitter Market
17.3 Sweden - CGM User
17.4 CGM Reimbursement in United States
18. Israel
18.1 Diabetes Population
18.1.1 Type 1
18.1.2 Type 2
18.2 Israel - CGM Market
18.2.1 Israel - CGM Market by Components
18.2.1.1 Glucose Sensor Market
18.2.1.2 CGM Transmitter Market
18.3 Israel - CGM User
18.4 CGM Reimbursement in United States
19. United Kingdom
19.1 Diabetes Population
19.1.1 Type 1
19.1.2 Type 2
19.2 United Kingdom - CGM Market
19.2.1 United Kingdom - CGM Market by Components
19.2.1.1 Glucose Sensor Market
19.2.1.2 CGM Transmitter Market
19.3 United Kingdom - CGM User
19.4 CGM Reimbursement in United States
20. Japan
20.1 Diabetes Population
20.1.1 Type 1
20.1.2 Type 2
20.2 Japan - CGM Market
20.2.1 Japan - CGM Market by Components
20.2.1.1 Glucose Sensor Market
20.2.1.2 CGM Transmitter Market
20.3 Japan - CGM User
20.4 CGM Reimbursement in United States
21 Company Analysis
21.1 Abbott Laboratories
21.1.1 Overview
21.1.2 Recent Development
21.1.3 Revenue
21.2 Roche
21.2.1 Overview
21.2.2 Recent Development
21.2.3 Revenue
21.3 Tandem Diabetes Care
21.3.1 Overview
21.3.2 Recent Development
21.3.3 Revenue
21.4 Dexcom Inc
21.4.1 Overview
21.4.2 Recent Development
21.4.3 Revenue
21.5 Senseonics
21.5.1 Overview
21.5.2 Recent Development
21.5.3 Revenue
List of Figures
Figure 01: Global - Continuous Glucose Monitoring Market (Million US$), 2017 - 2021
Figure 02: Global - Forecast for Continuous Glucose Monitoring Market (Million US$), 2022 - 2027
Figure 03: Global - Continuous Glucose Monitoring User Volume (Thousand), 2017 - 2021
Figure 04: Global - Forecast for Continuous Glucose Monitoring User Volume (Thousand), 2022 - 2027
Figure 05: Global - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 06: Global - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 07: Global - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 08: Global - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 09: United States - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 10: United States - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 11: United States - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 12: United States - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 13: United States - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 14: United States - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 15: United States - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 16: United States - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 17: United States - CGM User Volume (Number), 2017 - 2021
Figure 18: United States - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 19: Canada - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 20: Canada - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 21: Canada - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 22: Canada - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 23: Canada - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 24: Canada - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 25: Canada - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 26: Canada - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 27: Canada - CGM User Volume (Number), 2017 - 2021
Figure 28: Canada - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 29: Germany - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 30: Germany - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 31: Germany - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 32: Germany - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 33: Germany - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 34: Germany - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 35: Germany - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 36: Germany - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 37: Germany - CGM User Volume (Number), 2017 - 2021
Figure 38: Germany - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 39: Australia - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 40: Australia - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 41: Australia - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 42: Australia - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 43: Australia - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 44: Australia - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 45: Australia - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 46: Australia - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 47: Australia - CGM User Volume (Number), 2017 - 2021
Figure 48: Australia - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 49: France - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 50: France - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 51: France - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 52: France - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 53: France - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 54: France - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 55: France - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 57: France - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 56: France - CGM User Volume (Number), 2017 - 2021
Figure 58: France - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 59: Netherlands - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 60: Netherlands - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 61: Netherlands - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 62: Netherlands - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 63: Netherlands - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 64: Netherlands - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 65: Netherlands - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 66: Netherlands - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 67: Netherlands - CGM User Volume (Number), 2017 - 2021
Figure 68: Netherlands - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 69: Switzerland - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 70: Switzerland - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 71: Switzerland - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 72: Switzerland - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 73: Switzerland - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 74: Switzerland - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 75: Switzerland - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 76: Switzerland - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 77: Switzerland - CGM User Volume (Number), 2017 - 2021
Figure 78: Switzerland - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 79: Sweden - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 80: Sweden - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 81: Sweden - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 82: Sweden - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 83: Sweden - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 84: Sweden - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 85: Sweden - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 86: Sweden - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 87: Sweden - CGM User Volume (Number), 2017 - 2021
Figure 88: Sweden - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 89: Israel - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 90: Israel - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 91: Israel - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 92: Israel - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 93: Israel - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 94: Israel - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 95: Israel - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 96: Israel - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 97: Israel - CGM User Volume (Number), 2017 - 2021
Figure 98: Israel - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 99: United Kingdom - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 100: United Kingdom - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 101: United Kingdom - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 102: United Kingdom - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 103: United Kingdom - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 104: United Kingdom - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 105: United Kingdom - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 106: United Kingdom - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 107: United Kingdom - CGM User Volume (Number), 2017 - 2021
Figure 108: United Kingdom - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 109: Japan - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
Figure 110: Japan - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
Figure 111: Japan - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
Figure 112: Japan - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
Figure 113: Japan - Glucose Sensor Market (Million US$), 2017 - 2021
Figure 114: Japan - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
Figure 115: Japan - CGM Transmitter Market (Million US$), 2017 - 2021
Figure 116: Japan - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
Figure 117: Japan - CGM User Volume (Number), 2017 - 2021
Figure 118: Japan - Forecast for CGM User Volume (Number), 2022 - 2027
Figure 119: Abbott Laboratories - Global Revenue (Million US$), 2017 - 2021
Figure 120: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 121: Roche - Global Revenue (Million US$), 2017 - 2021
Figure 122: Roche - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 123: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2021
Figure 124: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 125: Dexcom Inc - Global Revenue (Million US$), 2017 - 2021
Figure 126: Dexcom Inc - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 127: Senseonics - Global Revenue (Million US$), 2017 - 2021
Figure 128: Senseonics - Forecast for Global Revenue (Million US$), 2022 - 2027
List of Tables
Table 01: Global - CGM Market Share by Countries (Percent), 2017 - 2021
Table 02: Global - Forecast for CGM Market Share by Countries (Percent), 2022 - 2027
Table 03: Global - Glucose Sensor Market Share by Countries (Percent), 2017 - 2021
Table 04: Global - Forecast for Glucose Sensor Market Share by Countries (Percent), 2022 - 2027
Table 05: Global - CGM Transmitter Market Share by Countries (Percent), 2017 - 2021
Table 06: Global - Forecast for CGM Transmitter Market Share by Countries (Percent), 2022 - 2027
Table 07: Global - CGM User Volume Share by Countries (Percent), 2017 - 2021
Table 08: Global - Forecast for CGM User Volume Share by Countries (Percent), 2022 - 2027

Companies Mentioned

  • Abbott Laboratories
  • Roche
  • Tandem Diabetes Care
  • Dexcom Inc
  • Senseonics

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information